Last updated: 10 September 2024 at 5:00pm EST

David Linetsky Net Worth




The estimated Net Worth of David Linetsky is at least $12.3 Million dollars as of 16 July 2024. Mr Linetsky owns over 1,820 units of Phreesia Inc stock worth over $4,715,724 and over the last 5 years he sold PHR stock worth over $7,015,905. In addition, he makes $578,458 as Sr. VP of Life Sciences at Phreesia Inc.

Mr Linetsky PHR stock SEC Form 4 insiders trading

Mr has made over 34 trades of the Phreesia Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,820 units of PHR stock worth $43,207 on 16 July 2024.

The largest trade he's ever made was selling 50,060 units of Phreesia Inc stock on 15 March 2021 worth over $3,058,666. On average, Mr trades about 6,641 units every 31 days since 2019. As of 16 July 2024 he still owns at least 202,218 units of Phreesia Inc stock.

You can see the complete history of Mr Linetsky stock trades at the bottom of the page.





Mr. David Linetsky biography

David Linetsky is the Sr. VP of Life Sciences at Phreesia Inc.

What is the salary of Mr Linetsky?

As the Sr. VP of Life Sciences of Phreesia Inc, the total compensation of Mr Linetsky at Phreesia Inc is $578,458. There are 4 executives at Phreesia Inc getting paid more, with Chaim Indig having the highest compensation of $10,474,400.



How old is Mr Linetsky?

Mr Linetsky is 42, he's been the Sr. VP of Life Sciences of Phreesia Inc since . There are 12 older and 3 younger executives at Phreesia Inc. The oldest executive at Phreesia Inc is Mark Smith, 68, who is the Independent Director.

What's Mr Linetsky's mailing address?

David's mailing address filed with the SEC is C/O PHREESIA, 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803.

Insiders trading at Phreesia Inc

Over the last 5 years, insiders at Phreesia Inc have traded over $277,935,884 worth of Phreesia Inc stock. The most active insiders traders include Edward L Cahill, Venture Partners Ii, L.P.Hl..., and Scott Perricelli. On average, Phreesia Inc executives and independent directors trade stock every 8 days with the average trade being worth of $1,320,099. The most recent stock trade was executed by Allison C Hoffman on 26 August 2024, trading 14,110 units of PHR stock currently worth $367,283.



What does Phreesia Inc do?

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.



What does Phreesia Inc's logo look like?

Phreesia Inc logo

Complete history of Mr Linetsky stock trades at Phreesia Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
16 Jul 2024 David Linetsky
SVP and Life Sciences
Sale 1,820 $23.74 $43,207
16 Jul 2024
202,218
21 Jun 2024 David Linetsky
SVP and Life Sciences
Sale 27 $20.24 $546
21 Jun 2024
6,953
18 Jun 2024 David Linetsky
SVP and Life Sciences
Sale 107 $19.53 $2,090
18 Jun 2024
6,980
18 Apr 2024 David Linetsky
SVP and Life Sciences
Sale 269 $22.85 $6,147
18 Apr 2024
7,087
15 Apr 2024 David Linetsky
SVP and Life Sciences
Sale 2,212 $22.86 $50,566
15 Apr 2024
204,038
8 Apr 2024 David Linetsky
SVP and Life Sciences
Sale 4,161 $22.62 $94,122
8 Apr 2024
7,356
20 Mar 2024 David Linetsky
SVP and Life Sciences
Sale 30 $23.66 $710
20 Mar 2024
7,095
18 Mar 2024 David Linetsky
SVP and Life Sciences
Sale 448 $23.16 $10,376
18 Mar 2024
7,125
16 Jan 2024 David Linetsky
SVP and Life Sciences
Sale 32,977 $24.15 $796,395
16 Jan 2024
204,059
18 Dec 2023 David Linetsky
SVP and Life Sciences
Sale 259 $23.21 $6,011
18 Dec 2023
7,573
16 Oct 2023 David Linetsky
SVP and Life Sciences
Sale 2,078 $16.61 $34,516
16 Oct 2023
215,036
18 Sep 2023 David Linetsky
SVP and Life Sciences
Sale 130 $19.67 $2,557
18 Sep 2023
7,832
12 Sep 2023 David Linetsky
SVP and Life Sciences
Option 11,853 $6.30 $74,674
12 Sep 2023
219,173
2 Feb 2023 David Linetsky
SVP and Life Sciences
Sale 11,378 $39.55 $450,000
2 Feb 2023
205,489
13 Dec 2022 David Linetsky
SVP and Life Sciences
Sale 11,377 $34.61 $393,758
13 Dec 2022
185,485
9 Dec 2022 David Linetsky
SVP and Life Sciences
Sale 26,837 $29.78 $799,206
9 Dec 2022
196,862
6 Jan 2022 David Linetsky
SVP and Life Sciences
Option 30,950 $5.32 $164,654
6 Jan 2022
171,338
5 Nov 2021 David Linetsky
SVP and Life Sciences
Option 4,977 $4.71 $23,442
5 Nov 2021
141,887
1 Nov 2021 David Linetsky
SVP and Life Sciences
Option 5,451 $4.71 $25,674
1 Nov 2021
145,839
15 Oct 2021 David Linetsky
SVP and Life Sciences
Option 5,452 $4.71 $25,679
15 Oct 2021
145,840
31 Aug 2021 David Linetsky
SVP and Life Sciences
Option 5,452 $4.71 $25,679
31 Aug 2021
145,366
27 Aug 2021 David Linetsky
SVP and Life Sciences
Option 21,455 $2.55 $54,710
27 Aug 2021
161,843
25 Aug 2021 David Linetsky
SVP and Life Sciences
Option 1,300 $2.55 $3,315
25 Aug 2021
141,188
4 May 2021 David Linetsky
SVP and Life Sciences
Option 45,510 $1.44 $65,534
4 May 2021
140,388
15 Mar 2021 David Linetsky
SVP and Life Sciences
Sale 50,060 $61.10 $3,058,666
15 Mar 2021
92,580
20 Jan 2021 David Linetsky
SVP and Life Sciences
Sale 6,826 $66.04 $450,789
20 Jan 2021
142,640
15 Jan 2021 David Linetsky
SVP and Life Sciences
Sale 5,136 $64.28 $330,142
15 Jan 2021
149,466
1 Oct 2020 David Linetsky
SVP and Life Sciences
Sale 4,477 $30.97 $138,653
1 Oct 2020
128,077
1 Jul 2020 David Linetsky
SVP and Life Sciences
Sale 4,475 $28.24 $126,374
1 Jul 2020
131,177
7 May 2020 David Linetsky
SVP and Life Sciences
Sale 255 $26.00 $6,630
7 May 2020
134,276
27 Apr 2020 David Linetsky
SVP and Life Sciences
Sale 4,220 $26.00 $109,720
27 Apr 2020
133,511
13 Mar 2020 David Linetsky
SVP and Life Sciences
Option 50,060 $0.83 $41,550
13 Mar 2020
136,355
18 Feb 2020 David Linetsky
SVP and Life Sciences
Sale 3,188 $32.85 $104,726
18 Feb 2020
86,295
30 Dec 2019 David Linetsky
SVP and Life Sciences
Option 3,413 $0.73 $2,491
30 Dec 2019
17,065


Phreesia Inc executives and stock owners

Phreesia Inc executives and other stock owners filed with the SEC include: